Impero (IMPERO) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
27 Jul, 2026Executive summary
Achieved strong finish in 2025 with DKK 3.1M net new ARR in Q4 and exceptionally low churn rate of 1% (LTM).
Significantly improved EBITDA for full-year 2025, reflecting balanced cost levels and improved operating efficiency.
Continued growth in the DACH region with no customer churn and successful launch of Control Testing module in July 2025.
Deepened AI integration across compliance lifecycle, enhancing feature delivery and platform stickiness.
Private placement of DKK 15M in December 2025 from existing shareholders, board, and management.
Financial highlights
Revenue increased 19% year-over-year to DKK 42.0M in 2025.
Gross profit margin improved to 98% in 2025 from 97% in 2024.
EBITDA improved to DKK -3.1M in 2025 from DKK -8.7M in 2024, driven by higher revenue growth and increased capitalization rate.
Annual Recurring Revenue (ARR) grew to DKK 46.2M at year-end 2025, up from DKK 38.7M in 2024.
Net revenue retention stood at 106% for 2025.
Outlook and guidance
ARR guidance for end of 2026 is DKK 53M to 57M, representing 15-23% growth.
EBITDA guidance for 2026 is DKK -2M to +1M, an improvement from 2025.
Assumes effective execution of go-to-market initiatives, high customer retention, timely commercial hires, and stable macroeconomic conditions.
Latest events from Impero
- 28% ARR and 29% revenue growth, improved EBITDA, and strong DACH expansion in H1 2024.IMPERO
Q2 202427 Jul 2026 - 31% ARR growth, strong retention, and positive cash flow highlight robust Q3 performance.IMPERO
Q3 202427 Jul 2026 - 28% ARR growth, improved EBITDA, and reduced churn set the stage for strong 2025 guidance.IMPERO
Q4 202427 Jul 2026 - 24% ARR growth, 27% revenue rise, and strong retention highlight robust Q1 2025 performance.IMPERO
Q1 202527 Jul 2026 - ARR up 15% to DKK 40.7M, revenue up 21%, EBITDA loss narrows, guidance maintained.IMPERO
Q2 202527 Jul 2026 - Record ARR growth, positive EBITDA, and strong DACH performance drive raised 2025 outlook.IMPERO
Q3 202527 Jul 2026 - 20% ARR growth, positive EBITDA, and strong DACH momentum drive upgraded 2026 outlook.IMPERO
Q1 202627 Jul 2026 - Entity Management, AI features, and Control Health drive upcoming platform enhancements.IMPERO
Investor update24 Jun 2026 - Strong ARR growth, AI-driven strategy, and all board proposals approved amid market uncertainties.IMPERO
AGM 202615 Apr 2026